Neonatal Hypoxic-Ischaemic Encephalopathy
Neonatal Hypoxic-Ischaemic Encephalopathy (HIE) is a brain injury that occurs in newborns when there is a lack of oxygen and blood flow to the brain, often leading to serious complications.
We are studying the safety and feasibility of using a baby's own cord blood stem cells to treat neonatal hypoxic ischemic encephalopathy. The trial also looks at how this treatment may help prevent long-term neurological problems.
Health conditions and diseases that the clinical trial is designed to study and treat.
Neonatal Hypoxic-Ischaemic Encephalopathy (HIE) is a brain injury that occurs in newborns when there is a lack of oxygen and blood flow to the brain, often leading to serious complications.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.